Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue

References

• Alessi M C, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor-1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860–867
   PubMed Web of Science ®Google Scholar
• Alessi M C, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I. Plasminogen activator inhibitor-1, transforming growth factor-beta 1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000; 49: 1374–1380
   PubMed Web of Science ®Google Scholar
• Alexander C M, Selvarajan S, Mudgett J, Werb Z. Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 2001; 152: 693–703
   PubMedGoogle Scholar
• Bajou K, Noel A, Gerard R D, Masson V, Brunner N, Holst-Hnasen C, Skobe M, Fusenig N E, Carmeliet P, Collen D, Foidart J M. Absence of host plasminogen activator inhibitor-1 prevents cancer invasion and vascularization. Nat Med 1998; 4: 923–928
   PubMed Web of Science ®Google Scholar
• Bouloumié A, Drescler H CA, Lafontan M, Busse R. Leptin, the product of the ob gene, promotes angiogenesis. Circ Res 1998; 83: 1059–1066
   PubMed Web of Science ®Google Scholar
• Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001; 50: 2080–2086
   PubMed Web of Science ®Google Scholar
• Bourlier V, Zakaroff-Girard A, De Barros S, Pizzacalla C, de Saint Front V D, Lafontan M, Bouloumié A, Galitzky J. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. J Pharmacol Exp Ther 2005; 312: 1272–1279
   PubMed Web of Science ®Google Scholar
• Brown L M, Fox H L, Hazen S A, LaNoue K F, Rannels S R, Lynch C J. Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. Am J Physiol 1997; 272: C937–C949
   PubMed Web of Science ®Google Scholar
• Crandall D L, Hausman E J, Kral J G. A review of the microcirculation of adipose tissue: anatomic, metabolic and aniogenic perspectives. Microcirculation 1997; 4: 211–232
   PubMed Web of Science ®Google Scholar
• Demeulemeester D, Collen D, Lijnen H R. Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Comm 2005; 329: 105–110
   PubMed Web of Science ®Google Scholar
• Demeulemeester D, Scroyen I, Voros G, Snoeys J, De Geest B, Collen D, Lijnen H R. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development. Thromb Haemost 2006; 95: 1019–1024
   PubMed Web of Science ®Google Scholar
• Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard R D, Gils A, Carmeliet G, Carmeliet P, Declerck P J, Noël A, Foidart J M. The pro- or antiangiogenic effect of plasminogen activator inhibitor-1 is dose-dependent. FASEB J 2002; 16: 147–154
   PubMedGoogle Scholar
• Dollery C M, McEwan J R, Henney A M. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863–868
   PubMed Web of Science ®Google Scholar
• Dussere E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500: 88–96
   PubMed Web of Science ®Google Scholar
• Eren M, Su M, Atkinson J, King L, Declerck P, Vaughan D E. Phenotypic derangements associated with overexpression of plasminogen activator inhibitor-1 in transgenic mice. Arterioscler Thromb Vasc Biol 2001; 21: 695, Abstract 230
   Web of Science ®Google Scholar
• Fain J N, Madan A K, Hiler M L, Cheema P, Bahouth S W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004; 145: 2273–2282
   PubMed Web of Science ®Google Scholar
• Friedman J M, Halaas J L. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770
   PubMed Web of Science ®Google Scholar
• Gomez D E, Alonso D F, Yoshiji H, Thorgeirsson U P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111–122
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. Febs Lett 1992; 298: 29–32
   PubMed Web of Science ®Google Scholar
• Hoover-Plow J, Ellis J, Yuen L. In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 2002; 87: 1011–1019
   PubMed Web of Science ®Google Scholar
• Johnson M D, Kim H R, Chesler L, Tsao-Wu G, Bouck N, Polverini P J. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994; 160: 194–202
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Alessi M C, Vague P. Increased plasma plasminogen activator inhibitor-1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457–462
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Maquoi E, Holvoet P, Mertens A, Lupu F, Morange P, Alessi M C, Juhan-Vague I. Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost 2001; 85: 1111–1116
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Maquoi E, Demeulemeester D, Van Hoef B, Collen D. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thromb Haemost 2002a; 88: 345–353
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Van Hoef B, Frederic L, Rio M C, Collen D. Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost 2002b; 87: 530–535
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Maqoui E, Hansen L B, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002c; 22: 374–379
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Juhan-Vague I. The fibrinolytic system and obesity. Thromb Haemost 2002d; 88: 882
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Maquoi E, Morange P E, Voros G, Van Hoef B, Kopp F, Collen D, Juhan-Vague I, Alessi M C. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 2003a; 23: 78–84
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Demeulemeester D, Van Hoef B, Collen D, Maquoi E. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 2003b; 89: 249–255
   PubMed Web of Science ®Google Scholar
• Lijnen H R. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2004; 3: 35–45
   Web of Science ®Google Scholar
• Lijnen H R. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity on mice. Thomb Haemost 2005; 93: 816–819
   PubMed Web of Science ®Google Scholar
• Lijnen H R, Collen D. Molecular and cellular basis of fibrinolysis. Hematology: basic principles and practice. 4th ed., R Hoffman, E J Benz, S J Shattil, B Furie, H J Cohen, L E Silberstein, P McGlave. Elsevier, Philadelphia 2005; 1955–1959
   Google Scholar
• Ma L F, Mao S L, Taylor K L, Kanjanabuch T, Guan Y, Zhang Y, Brown N G, Swift L L, McGuinness O P, Wasserman D H, Vaughan D E, Fogo A B. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor-1. Diabetes 2004; 53: 336–346
   PubMed Web of Science ®Google Scholar
• Maquoi E, Munaut C, Colige A, Collen D, Lijnen H R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093–1101
   PubMed Web of Science ®Google Scholar
• Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen H R. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 2003; 89: 696–704
   PubMed Web of Science ®Google Scholar
• Mavri A, Stegnar M, Krebs M, Sentocnik J T, Geiger M, Binder B R. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vasc Biol 1999; 19: 1582–1587
   PubMed Web of Science ®Google Scholar
• Miskin R, Masos T. Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption body weight and size, and increased longevity. J Gerontol 1997; 52A: B118–B124
   Google Scholar
• Morange P E, Lijnen H R, Alessi M C, Kopp F, Collen D, Juhan-Vague I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 2000; 20: 1150–1154
   PubMed Web of Science ®Google Scholar
• Morange P E, Bastelica D, Bonzi M F, Van Hoef B, Collen D, Juhan-Vague I, Lijnen H R. Influence of t-PA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Thromb Haemost 2002; 87: 306–310
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner J F. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–21494
   PubMed Web of Science ®Google Scholar
• Nakajima I, Yamagushi T, Ozutsumi K, Aso H. Adipose tissue ECM: newly organized by adipocytes during differentiation. Differentiation 1998; 63: 193–200
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer F X. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002; 10: 97S–104S, (Suppl 2)
   PubMedGoogle Scholar
• Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–674
   PubMed Web of Science ®Google Scholar
• Rossner S. Obesity; the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002; 26: S2–S4, (Suppl 2)
   PubMed Web of Science ®Google Scholar
• Rupnick M A, Panigrahy D, Zhang C Y, Dallabrida S M, Lowell B B, Langer R, Folkman M J. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730–10735
   PubMed Web of Science ®Google Scholar
• Samad F, Loskutoff D J. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996; 2: 568–582
   PubMed Web of Science ®Google Scholar
• Sarmiento U, Benson B, Kaufman S, Ross L, Qi M, Scully S, DiPalma C. Morphologic and molecular changes induced by recombinant human leptin in the white and brown adipose tissues of C57BL/6 mice. Lab Invest 1997; 77: 243–256
   PubMed Web of Science ®Google Scholar
• Schäfer K, Fujisawa K, Konstantinides S, Loskutoff D J. Disruption of the plasminogen activator inhibitor-1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001; 15: 1840–1842
   PubMed Web of Science ®Google Scholar
• Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800–803
   PubMed Web of Science ®Google Scholar
• Sierra-Honigman M R, Nath A K, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa W C, Madge L A, Schechner J S, Schwabb M B, Polverini P J, Flores-Riveros J R. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683–1686
   PubMed Web of Science ®Google Scholar
• Tenkanen L, Manttari M, Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation 1995; 92: 1779–1785
   PubMed Web of Science ®Google Scholar
• Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen H R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005; 146: 4545–4554
   PubMed Web of Science ®Google Scholar
• Willenbrock F, Murphy G. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994; 150: S165–S170
   Google Scholar